Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Drugs Made In America Acq...

    NASDAQ: DMAA · Real-Time Price · USD
    10.27
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:39 PM
    10.29
    0.19%
    After-hours: Oct 03, 2025, 04:04 PM EDT

    Drugs Made In America Acquisition Ordinary Shares Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024
    Period Ending Dec 31, 2024
    Net Income
    		 -479
    Depreciation & Amortization
    		 n/a
    Stock-Based Compensation
    		 n/a
    Other Working Capital
    		 132.48
    Other Non-Cash Items
    		 -171.92K
    Deferred Income Tax
    		 n/a
    Change in Working Capital
    		 132.48
    Operating Cash Flow
    		 -172.26K
    Capital Expenditures
    		 5.00
    Cash Acquisitions
    		 n/a
    Purchase of Investments
    		 n/a
    Sales Maturities Of Investments
    		 n/a
    Other Investing Acitivies
    		 n/a
    Investing Cash Flow
    		 n/a
    Debt Repayment
    		 502.21K
    Common Stock Repurchased
    		 n/a
    Dividend Paid
    		 n/a
    Other Financial Acitivies
    		 n/a
    Financial Cash Flow
    		 173.62K
    Net Cash Flow
    		 1.35K
    Free Cash Flow
    		 -295

    Add to Watchlist